| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.7 |